Cytokines — The New Generation of Adjuvants for Vaccines?
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
The Effects of Cyclosporin A on the Immune System
1985 • 442 citations
Role of Cytokines and CD4+ T‐Cell Subsets in the Regulation of Parasite Immunity and Disease
1989 • 405 citations
T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice
1980 • 228 citations
Prevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expression
1987 • 216 citations
The adjuvanticity of interleukin 1 in vivo.
1983 • 197 citations
LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC IMMUNE RESPONSES AGAINST HBsAg IN IMMUNODEFICIENT NON-RESPONDERS TO HEPATITIS B VACCINATION
1989 • 174 citations
Effect of IFN-γ on the immune response in vivo and on gene expression in vitro
1984 • 149 citations
Immunomodulatory properties of recombinant murine and human tumor necrosis factor.
1988 • 128 citations
Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
1988 • 114 citations
Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo.
1988 • 110 citations
In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.
1987 • 95 citations
Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness.
1985 • 95 citations
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice.
1987 • 89 citations
The role of interleukin 2 in autoimmunity
1989 • 89 citations
Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange.
1989 • 87 citations
Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2.
1988 • 67 citations
The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment
1989 • 65 citations
Recombinant murine IL-3 fails to stimulate T or B lymphopoiesis in vivo, but enhances immune responses to T cell-dependent antigens.
1988 • 49 citations
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production.
1985 • 49 citations
In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice.
1988 • 48 citations
Interferon-gamma as an adjuvant in immunocompromised mice.
1989 • 48 citations
Enhancement of a secondary antibody response to vesicular stomatitis virus "G" protein by IFN-gamma treatment at primary immunization.
1988 • 46 citations
New Approaches to Vaccine Development
1989 • 39 citations
Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon.
1988 • 37 citations
New approaches in vaccine development
1998 • 34 citations
Involvement of gamma interferon in antibody enhancement by adjuvants
1990 • 31 citations
Immune Responses of Cattle and Mice to the G Glycoprotein of Vesicular Stomatitis Virus
1985 • 23 citations
The Effect of Injection Methods on the Species Specificity of Serum Precipitins
1935 • 16 citations
Vaccinia‐Interleukin 2 Recombinant Virus or Exogenous Interleukin 2 Does Not Alter the Magnitude or Immune Response Gene Defects of the Cytotoxic T‐Cell Response to Vaccinia Virus in Vivo
1989 • 10 citations